Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Biological Products, (No Diagnostic Substances).
The next scheduled catalyst is Next quarterly earnings (projected) on December 12, 2026, a projected date rather than a confirmed one. There are 2 upcoming events on record.
Cash runway is approximately 2.3 months based on the most recent reported cash position and quarterly operating burn as of 2026-06-30.
| Date | Event | Type | Phase |
|---|---|---|---|
| December 12, 2026 est. | Next quarterly earnings (projected) | Earnings | — |
| December 15, 2027 | A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders | Trial Milestone | Phase 3 |
Track OTLK alongside other companies. Add it to a watchlist and see every catalyst on one calendar.
Open OTLK in the tracker| Date | Event | Type | Phase |
|---|---|---|---|
| September 30, 2026 | 8-K filed: Listing / standard notice | Corporate | — |
| September 18, 2026 | 8-K filed: Other event | Filing | — |
| August 27, 2026 | 8-K filed: Leadership change | Corporate | — |
| August 14, 2026 | Quarterly results filed (8-K) | Earnings | — |
| August 14, 2026 | 8-K filed: Other event | Filing | — |
| August 12, 2026 | Quarterly results filed (8-K) | Earnings | — |
| July 24, 2026 | 8-K filed: Leadership change | Corporate | — |
| July 24, 2026 | 8-K filed: Other event | Filing | — |
| June 26, 2026 | 8-K filed: Listing / standard notice | Corporate | — |
| June 16, 2026 | 8-K filed: Other event | Filing | — |
| June 1, 2026 | 8-K filed: Other event | Filing | — |
| May 29, 2026 | 8-K filed: Other event | Filing | — |
| May 28, 2026 | 8-K filed: Other event | Filing | — |
| May 26, 2026 | 8-K filed: Other event | Filing | — |
| May 18, 2026 | Quarterly results filed (8-K) | Earnings | — |
| May 13, 2026 | Quarterly results filed (8-K) | Earnings | — |
| April 23, 2026 | 8-K filed: Other event | Filing | — |
| April 21, 2026 | 8-K filed: Other event | Filing | — |
| April 7, 2026 | 8-K filed: Other event | Filing | — |
| March 25, 2026 | 8-K filed: Other event | Filing | — |
| March 16, 2026 | 8-K filed: Material agreement, Other event | Corporate | — |
| March 11, 2026 | 8-K filed: Leadership change | Corporate | — |
| March 5, 2026 | 8-K filed: Other event | Filing | — |
| February 18, 2026 | 8-K filed: Listing / standard notice | Corporate | — |
| February 17, 2026 | Quarterly results filed (8-K) | Earnings | — |
| February 11, 2026 | 8-K filed: Other event | Filing | — |
| January 2, 2026 | 8-K filed: Other event | Filing | — |
| December 19, 2025 | Quarterly results filed (8-K) | Earnings | — |
| November 13, 2025 | 8-K filed: Other event | Filing | — |
| November 3, 2025 | 8-K filed: Other event | Filing | — |
Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.
Last updated 2026-10-14.